Written by
Share article:
Paige, a vendor focused on applying AI to some of the biggest problems in cancer care, has recently unveiled a clinically focused, multimodal co-pilot designed to help facilitate precision oncology.
The tool, dubbed Alba, utilised Paige’s foundation models to deliver AI- driven patient insights in real-time and according to the vendor represents a significant step forward in the incorporation of generative AI into digital pathology.
Why we are covering this topic
– Paige is among the digital pathology vendors most rapidly turning to generative AI
– Digital pathology is an area in which generative AI can have a significant impact
Why it matters
– Paige’s new Alba solution is among the most comprehensive co-pilots for digital pathology, potentially opening new possibilities for pathologists and the labs in which they work
– The tools integration could allow it to have more significant impact than some of its peers
– Paige’s Alba solution is not yet available commercially, as with other pathology and oncology focused vendors, Paige is still stymied by obstacles common to the market
